NIT
GOSS icon

NumerixS Investment Technologies’s Gossamer Bio GOSS Stock Holding History

NumerixS Investment Technologies’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-6,200
Closed -$63K – 1155
2020
Q1 		$63K Sell
6,200
-3,400
-35% -$44.4K 0.03% 557
2019
Q4 		$150K Buy
+9,600
New +$193K 0.03% 576

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

NumerixS Investment Technologies's GOSS Position: Q2 2020 in Review

NumerixS Investment Technologies sold out of Gossamer Bio (GOSS) in Q2 2020, closing a stake of 6,200 shares — an estimated $63K sold.

NumerixS Investment Technologies first reported a position in GOSS in Q4 2019 and held it in 2 quarters. The position peaked at $150K in Q4 2019. 110 funds tracked by Wall St. Rank hold GOSS as of Q2 2020.

  • NumerixS Investment Technologies reported no remaining Gossamer Bio position as of Q2 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 6,200 Gossamer Bio shares in Q2 2020, an estimated $63K.
  • NumerixS Investment Technologies first reported a position in Gossamer Bio in Q4 2019 and held it in 2 quarters.
  • NumerixS Investment Technologies's Gossamer Bio position peaked at $150K in Q4 2019.
  • 110 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2020.

Based on NumerixS Investment Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.